Evidence map›Paper›PMID 32260176›Full record

ReviewCells2020

MeCP2 and Chromatin Compartmentalization.

Annika Schmidt, Hui Zhang, M Cristina Cardoso

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Biomolecules · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. State-of-the-art therapies for Rett syndrome.Developmental medicine and child neurology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Annika SchmidtDepartment of Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany.
Hui ZhangDepartment of Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany.
M Cristina CardosoDepartment of Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany.ORCID 0000-0001-8427-8859
Technische Universität Darmstadt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methyl-CpG binding protein 2 (MeCP2) is a multifunctional epigenetic reader playing a role in transcriptional regulation and chromatin structure, which was linked to Rett syndrome in humans. Here, we focus on its isoforms and functional domains, interactions, modifications and mutations found in Rett patients. Finally, we address how these properties regulate and mediate the ability of MeCP2 to orchestrate chromatin compartmentalization and higher order genome architecture.

Indexed as

AnimalsChromatinHumansMethyl-CpG-Binding Protein 2Models, BiologicalProtein BindingProtein Processing, Post-TranslationalRett SyndromeChromatinMethyl-CpG-Binding Protein 2DNA methylation readersDNA modificationsheterochromatinhigher order chromatin structureMeCP2Rett syndrome

Identifiers

PMID32260176
PMCPMC7226738
OpenAlexW3014542843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.